Comments to FDA: Probiotics Labeling

Share page:

Comments | Nov 6, 2018

Docket Number:
FDA-2011-D-0376

Herein CHPA provides feedback on FDA’s recent draft guidance document addressing the labeling of dietary supplements containing live microbials (also referred to as probiotics).

Related Posts

hands in sterile gloves holding manufactured white tablets

Voluntary Codes and Guidelines

SIDI Protocol Version 3.0